Previous Section
Review Articles
1. The evolving role of lenalidomide in the treatment of hematologic malignancies.
- Author
- Kastritis E; Dimopoulos MA; Kastritis E; Dimopoulos MA;
- Institution
- Department of Clinical Therapeutics, Alexandra Hospital, University of Athens, School of Medicine, Athens, Greece.
- Journal
- Expert Opin Pharmacother. 2007 Mar;8(4):497-509.
- Abstract URL
- Click here to view abstract
2. Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations.
- Author
- Hussein MA;
- Institution
- Multiple Myeloma Multidisciplinary Clinical Research Program, Cleveland Clinic Taussig Cancer Center, 9500 Euclid Ave, Ohio 44195, USA. mashussein@runbox.us
- Journal
- Thromb Haemost. 2006 Jun;95(6):924-30.
- Abstract URL
- Click here to view abstract
3. One or two autografts for myeloma?
- Author
- Mehta J;
- Institution
- Journal
- Blood. 2008 Apr 1;111(7):3899-900.
4. Oncolytic virotherapy for multiple myeloma.
- Author
- Stief AE; McCart JA;
- Institution
- Experimental Therapeutics, Toronto General Research Institute, 67 College Street, Room 4-408, Toronto, ON, M5G 2M1, Canada.
- Journal
- Expert Opin Biol Ther. 2008 Apr;8(4):463-73.
- Abstract URL
- Click here to view abstract
5. Multiple myeloma.
- Author
- Kyle RA; Rajkumar SV;
- Institution
- Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA. kyle.robert@mayo.edu
- Journal
- Blood. 2008 Mar 15;111(6):2962-72.
- Abstract URL
- Click here to view abstract
6. The use of thalidomide in myeloma therapy as an effective anticancer drug.
- Author
- Sze DM; Brown R; Yang S; Ho PJ; Gibson J; Joshua D;
- Institution
- Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. d.sze@pharm.usyd.edu.au
- Journal
- Curr Cancer Drug Targets. 2006 Jun;6(4):325-31.
- Abstract URL
- Click here to view abstract
7. A kinder, gentler way: control of the proliferative tumor compartment, not cosmetic complete response, should be the goal of myeloma therapy.
- Author
- Bergsagel PL;
- Institution
- Journal
- Leukemia. 2008 Apr;22(4):673-5.
8. Modern treatment options for elderly patients with multiple myeloma.
- Author
- Gorner M; Spath-Schwalbe E;
- Institution
- Klinik fur Hamatologie und Onkologie, Stadtische Kliniken Bielefeld gGmbH, Bielefeld,Germany. martin.goerner@sk-bielefeld.de
- Journal
- Onkologie. 2008 Jun;31(6):335-42. Epub 2008 May 27.
- Abstract URL
- Click here to view abstract
9. Multiple myeloma cancer stem cells.
- Author
- Huff CA; Matsui W;
- Institution
- Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University School of Medicine, CRB245, 1650 Orleans St, Baltimore, MD 21231, USA.
- Journal
- J Clin Oncol. 2008 Jun 10;26(17):2895-900.
- Abstract URL
- Click here to view abstract
10. Individualizing treatment of patients with myeloma in the era of novel agents.
- Author
- San-Miguel J; Harousseau JL; Joshua D; Anderson KC;
- Institution
- Servicio de Hematologia, Hospital Universitario de Salamanca, Paseo de San Vicente, 58, 37007 Salamanca, Spain. sanmigiz@usal.es
- Journal
- J Clin Oncol. 2008 Jun 1;26(16):2761-6. Epub 2008 Apr 21.
- Abstract URL
- Click here to view abstract
